During the past decade, Osaka University Hospital conducted 174 clinical trials. In the 10-year time frame, 174 clinical trials started and 74 clinical trials were completed, i.e. on average, 42.5% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 53 clinical trials were completed. i.e. 54.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka University Hospital" #1 sponsor was "Pfizer" with 19 trials, followed by "Osaka University" with 12 trials sponsored, "Takeda" with 11 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "Janssen Research & Development, LLC" with 10 trials sponsored. Other sponsors include 164 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka University Hospital" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Eisai Inc." with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Osaka University Hospital" are "Achondroplasia" (6 trials), "Aortic Valve Stenosis" (5 trials), "Heart Failure" (5 trials), "Colorectal Cancer" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "Osaka University Hospital" in a lesser frequency.

Most popular intervention types in "Osaka University Hospital" are "Drug" (176 trials), "Device" (27 trials), "Biological" (24 trials), "Other" (15 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Cisplatin" (6 trials), "Atezolizumab" (5 trials), "Filgotinib" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Osaka University Hospital" are 216 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Osaka University Hospital". undefined are not yet recruiting, 53 are recruiting, 41 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 104 completed trials in Osaka University Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka University Hospital, 23 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 24 trials that are defined as “Not Applicable".